2011
DOI: 10.5978/islsm.20.23
|View full text |Cite
|
Sign up to set email alerts
|

The Aesthetic Applications of Intense Pulsed Light Using the Lumenis M-22 Device

Abstract: Background: Fifteen years have passed since the first Intense Pulsed Light (IPL) devices were introduced into the market. A variety of devices that use light energy for aesthetic puposes are currently manufactured by several companies, and newer devices offering improved performance and features are periodically being introduced. Herein we present our experience with the MP-22 device (Lumenis Ltd.,Yokneam, Israel) for cosmetic treatment of benign skin lesions. Patients and Methods:We collected patient data fro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 14 publications
(2 reference statements)
0
3
0
Order By: Relevance
“…Ullmann et al used the MP-22 device to treat several benign lesions (e.g., lentigo and vascular lesions) with 93% of participants reporting satisfaction and no major adverse events observed. 80 Radio frequency treatment can also be utilized for managing the aging skin. 81 Radio frequency devices function by penetrating the skin with microneedles that cause partial destruction to the underlying epidermis and dermis.…”
Section: Lasers and Ablative Solutionsmentioning
confidence: 99%
See 1 more Smart Citation
“…Ullmann et al used the MP-22 device to treat several benign lesions (e.g., lentigo and vascular lesions) with 93% of participants reporting satisfaction and no major adverse events observed. 80 Radio frequency treatment can also be utilized for managing the aging skin. 81 Radio frequency devices function by penetrating the skin with microneedles that cause partial destruction to the underlying epidermis and dermis.…”
Section: Lasers and Ablative Solutionsmentioning
confidence: 99%
“…Ullmann et al used the MP-22 device to treat several benign lesions (e.g., lentigo and vascular lesions) with 93% of participants reporting satisfaction and no major adverse events observed. 80…”
Section: Lasers and Ablative Solutionsmentioning
confidence: 99%
“…The use of visible light (>380 nm) with appropriate PIs can increase the safety of the photo‐crosslinking process by removing exposure to harmful mutagenic light wavelengths, thus maximizing cell viability and reducing the risk of malignant transformation. It has been shown that light at visible wavelength penetrate tissues at higher depths with lower energy compared with UV light, thus making it an efficient source for in situ photo‐crosslinking . Challenges to visible light crosslinking include the identification of a PI that is sensitive to visible wavelengths as well as identification of the optimal exposure time and power of the light source.…”
Section: Strategies To Reduce Cytotoxicitymentioning
confidence: 99%